Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients

Background and Aim Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and i...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastroenterology and hepatology Vol. 28; no. 9; pp. 1555 - 1564
Main Authors Wu, Han, Chen, Pei, Liao, Rui, Li, Yi-Wei, Yi, Yong, Wang, Jia-Xing, Cai, Xiao-Yan, He, Hong-Wei, Jin, Jian-Jun, Cheng, Yun-Feng, Fan, Jia, Sun, Jian, Qiu, Shuang-Jian
Format Journal Article
LanguageEnglish
Published Australia Blackwell Publishing Ltd 01.09.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background and Aim Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). Methods  The frequencies and phenotypes of CD4+CD25+CD127low/−CD49d− Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg‐cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real‐time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. Results  Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol‐anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor‐immuno‐related Gene Ontology terms were significantly affected. Conclusions  Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression.
AbstractList Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). The frequencies and phenotypes of CD4+CD25+CD127low/-CD49d- Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg-cell suppressive activity was determined using an in vitroCD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol-anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor-immuno-related Gene Ontology terms were significantly affected. Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression.
Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). METHODS : The frequencies and phenotypes of CD4(+) CD25(+) CD127(low/-) CD49d(-) Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg-cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. RESULTS : Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol-anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor-immuno-related Gene Ontology terms were significantly affected. CONCLUSIONS : Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression.
Background and Aim Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). Methods  The frequencies and phenotypes of CD4+CD25+CD127low/−CD49d− Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg‐cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real‐time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. Results  Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol‐anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor‐immuno‐related Gene Ontology terms were significantly affected. Conclusions  Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression.
Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). METHODS : The frequencies and phenotypes of CD4(+) CD25(+) CD127(low/-) CD49d(-) Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg-cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. RESULTS : Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol-anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor-immuno-related Gene Ontology terms were significantly affected. CONCLUSIONS : Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression.BACKGROUND AND AIMRegulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). METHODS : The frequencies and phenotypes of CD4(+) CD25(+) CD127(low/-) CD49d(-) Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg-cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. RESULTS : Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol-anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor-immuno-related Gene Ontology terms were significantly affected. CONCLUSIONS : Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression.
Author Wu, Han
He, Hong-Wei
Fan, Jia
Liao, Rui
Yi, Yong
Sun, Jian
Cheng, Yun-Feng
Qiu, Shuang-Jian
Cai, Xiao-Yan
Wang, Jia-Xing
Jin, Jian-Jun
Li, Yi-Wei
Chen, Pei
Author_xml – sequence: 1
  givenname: Han
  surname: Wu
  fullname: Wu, Han
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 2
  givenname: Pei
  surname: Chen
  fullname: Chen, Pei
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 3
  givenname: Rui
  surname: Liao
  fullname: Liao, Rui
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 4
  givenname: Yi-Wei
  surname: Li
  fullname: Li, Yi-Wei
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 5
  givenname: Yong
  surname: Yi
  fullname: Yi, Yong
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 6
  givenname: Jia-Xing
  surname: Wang
  fullname: Wang, Jia-Xing
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 7
  givenname: Xiao-Yan
  surname: Cai
  fullname: Cai, Xiao-Yan
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 8
  givenname: Hong-Wei
  surname: He
  fullname: He, Hong-Wei
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 9
  givenname: Jian-Jun
  surname: Jin
  fullname: Jin, Jian-Jun
  organization: Biomedical Research Center, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 10
  givenname: Yun-Feng
  surname: Cheng
  fullname: Cheng, Yun-Feng
  organization: Biomedical Research Center, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 11
  givenname: Jia
  surname: Fan
  fullname: Fan, Jia
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 12
  givenname: Jian
  surname: Sun
  fullname: Sun, Jian
  email: Shuang-Jian Qiu, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China. Email: andJian Sun, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China. , qiu.shuangjian@zs-hospital.sh.cnsun.jian1@zs-hospital.sh.cn
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 13
  givenname: Shuang-Jian
  surname: Qiu
  fullname: Qiu, Shuang-Jian
  email: Shuang-Jian Qiu, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China. Email: andJian Sun, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China. , qiu.shuangjian@zs-hospital.sh.cnsun.jian1@zs-hospital.sh.cn
  organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23517245$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtv1DAUhS1URKeFBX8AeQmLtH7FSZaoaqetqiJQEUvLsW8mLnlhO1Py7_EwbRdIILyxdPSdo3vvOUIHwzgAQm8pOaHpnd5v2hPKGGEv0IoKQTJaCHmAVqSkeVZxWh2ioxDuCSGCFPkrdMh4Tgsm8hVarobodZz70esOe9jMnY6jX_AdNtB1AT-42OLWbVrwePKw1R0MBrAeLE4ewGGekhyC2ybRRLd1ccFuwC1MKWiXkRI9NtobN4y9xkl2MMTwGr1sdBfgzeN_jL5enN-dXWY3n9ZXZx9vMsMryTJuJdHallUpWd7kFZCiEaxpZJk3FErKamltqTVQTWpbFya3tSyZ4EXBrDANP0bv97mTH3_MEKLqXdjNpQcY56Co4BVjJZPF_6CcyTQHSei7R3Sue7Bq8q7XflFPl03Ahz1g_BiCh-YZoUTtWlOpNfW7tcSe_sEaF9OZxl03rvuX48F1sPw9Wl2vL58c2d7hQoSfzw7tv6u0eZGrb7drJdkFW9MvQn3mvwD8T7la
CitedBy_id crossref_primary_10_18632_oncotarget_17340
crossref_primary_10_1016_j_jcyt_2018_06_002
crossref_primary_10_1016_j_critrevonc_2015_01_009
crossref_primary_10_1016_j_imbio_2021_152113
crossref_primary_10_1038_cmi_2016_4
crossref_primary_10_1002_lci2_22
crossref_primary_10_1002_lt_24050
crossref_primary_10_1111_vco_12383
crossref_primary_10_1111_bjh_17070
crossref_primary_10_1186_s43066_023_00250_2
crossref_primary_10_1016_j_canlet_2015_03_003
crossref_primary_10_1016_j_cdtm_2016_09_001
crossref_primary_10_1038_srep10665
crossref_primary_10_2174_1871520618666181114112431
crossref_primary_10_1186_2051_1426_2_S3_P240
crossref_primary_10_1155_2015_731469
Cites_doi 10.1038/sj.bjc.6604149
10.1093/intimm/dxl060
10.1038/75556
10.1158/1078-0432.CCR-10-1073
10.1016/j.jneuroim.2010.10.015
10.1007/s00432-010-0833-8
10.1038/nm1292
10.1200/JCO.2008.18.7229
10.1016/j.jhep.2006.01.036
10.1186/1753-6561-3-s4-s11
10.1385/IR:32:1-3:031
10.4049/jimmunol.0900753
10.1128/IAI.00513-10
10.1016/j.jhep.2010.07.044
10.1002/hep.20644
10.1016/j.biocel.2007.03.022
10.1038/nri1026
10.1038/ni.1929
10.1016/j.exphem.2006.04.016
10.1158/0008-5472.CAN-08-2360
10.1038/nm1293
10.1038/nm1093
10.1084/jem.193.11.F41
10.1038/jid.2009.313
10.1126/science.1203486
10.1038/ni.1915
10.1182/blood-2008-04-150524
10.1158/1078-0432.CCR-07-0472
10.1200/JCO.2007.15.6521
10.4049/jimmunol.155.3.1151
10.1038/nature05673
10.1309/AJCP86PPBNGOHNNL
10.1111/j.1349-7006.2009.01182.x
10.1084/jem.20060772
10.1200/JCO.2006.09.4565
10.1158/1078-0432.CCR-08-1608
10.1016/j.gde.2007.12.007
10.1371/journal.pone.0008894
10.1038/nature01315
10.4049/jimmunol.0901099
10.1038/nri1806
10.1016/j.jim.2011.07.001
10.1007/s00262-007-0343-y
10.1111/j.1600-065X.2011.01007.x
10.1016/S0966-3274(02)00013-8
ContentType Journal Article
Copyright 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd
2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.
Copyright_xml – notice: 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd
– notice: 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
DOI 10.1111/jgh.12202
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1440-1746
EndPage 1564
ExternalDocumentID 23517245
10_1111_jgh_12202
JGH12202
ark_67375_WNG_62F2G1R4_Q
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Key Sci‐Tech Special Project of China
  funderid: 2012ZX10002011‐002; 2012ZX10002010‐001‐002
– fundername: National Natural Science Foundation of China
  funderid: 81071707; 81071995; 81030038
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
DU5
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KMS
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
ID FETCH-LOGICAL-c3962-3d60aad898625f59e07f42ff685f1e812b6dd8aae1a0bdb7c5db68243772d4cf3
IEDL.DBID DR2
ISSN 0815-9319
1440-1746
IngestDate Fri Jul 11 00:54:48 EDT 2025
Fri Jul 11 11:51:58 EDT 2025
Mon Jul 21 05:25:04 EDT 2025
Tue Jul 01 01:45:03 EDT 2025
Thu Apr 24 23:11:32 EDT 2025
Wed Jan 22 16:53:04 EST 2025
Wed Oct 30 09:51:16 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords gene microarray
immunosuppression
tumor immuno-escape
regulatory T cell
hepatocellular carcinoma
Language English
License 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3962-3d60aad898625f59e07f42ff685f1e812b6dd8aae1a0bdb7c5db68243772d4cf3
Notes National Natural Science Foundation of China - No. 81071707; No. 81071995; No. 81030038
National Key Sci-Tech Special Project of China - No. 2012ZX10002011-002; No. 2012ZX10002010-001-002
Figure S1 Hierarchical clustering of the 2.0-fold upregulated and downregulated genes in tumor-infiltrating Tregs (pooled samples) compared with peritumoral Tregs (pooled samples). T, tumor-infiltrating Treg cell; P, peritumoral Treg cell. Figure S2 Significant upregulated pathways in Tumor-infiltrating Tregs compared with peritumor using KEGG PATHWAY database. (a) Complement cascade pathway. (b) P53 signaling pathway. Upregulated genes are highlighted in red. Figure S3 Significantly changed glycosylation pathways in Tumor-infiltrating Tregs compared with peritumor using KEGG PATHWAY database. (a) Salivary secretion signaling pathway. Downregulated genes are highlighted in yellow. (b) Glycosylphosphatidylinositol-anchor biosynthesis signaling pathway. Upregulated genes are highlighted in red. Table S1 Primer sequence. Table S2 Complete list of differentially expressed genes of tumor-infiltrating Treg cells compared to peritumor. Table S3 Complete list of upregulated KEGG pathways based on the upregulated genes of tumor-infiltrating Treg cells compared to peritumor. Table S4 Complete list of downregulated KEGG pathways based on the downregulated genes of tumor-infiltrating Treg cells compared to peritumor. Table S5 Complete list of the upregulated GO terms based on the upregulated genes of tumor-infiltrating Treg cells compared to peritumor. Table S6 Complete list of the downregulated GO terms based on the downregulated genes of tumor-infiltrating Treg cells compared to peritumor.
ArticleID:JGH12202
istex:3E65E1108F82E0C1915E7ECE7118A80213ABFE1D
ark:/67375/WNG-62F2G1R4-Q
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 23517245
PQID 1433266250
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_1439228267
proquest_miscellaneous_1433266250
pubmed_primary_23517245
crossref_primary_10_1111_jgh_12202
crossref_citationtrail_10_1111_jgh_12202
wiley_primary_10_1111_jgh_12202_JGH12202
istex_primary_ark_67375_WNG_62F2G1R4_Q
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2013
PublicationDateYYYYMMDD 2013-09-01
PublicationDate_xml – month: 09
  year: 2013
  text: September 2013
PublicationDecade 2010
PublicationPlace Australia
PublicationPlace_xml – name: Australia
PublicationTitle Journal of gastroenterology and hepatology
PublicationTitleAlternate J Gastroenterol Hepatol
PublicationYear 2013
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Curr. Opin. Genet. Dev. 2008; 18: 11-18.
Long ET, Baker S, Oliveira V, Sawitzki B, Wood KJ. Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice. PLoS ONE 2010; 5: e8894.
Staun-Ram E, Miller A. Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-beta and role played in cell migration. J. Neuroimmunol. 2011; 232: 200-206.
Bonnet A, Lagarrigue S, Liaubet L, Robert-Granie C, Sancristobal M, Tosser-Klopp G. Pathway results from the chicken data set using GOTM, Pathway Studio and Ingenuity softwares. BMC Proc. 2009; 3 (Suppl. 4): S11.
Sugimoto N, Oida T, Hirota K et al. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 2006; 18: 1197-1209.
Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006; 6: 295-307.
Salama P, Phillips M, Grieu F et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 2009; 27: 186-192.
Quezada SA, Peggs KS, Simpson TR, Allison JP. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol. Rev. 2011; 241: 104-118.
Hawiger D, Wan YY, Eynon EE, Flavell RA. The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell-mediated peripheral T cell unresponsiveness. Nat. Immunol. 2010; 11: 962-968.
Ju MJ, Qiu SJ, Gao Q et al. Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Sci. 2009; 100: 1267-1274.
Ju MJ, Qiu SJ, Fan J et al. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am. J. Clin. Pathol. 2009; 131: 498-510.
Unitt E, Rushbrook SM, Marshall A et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005; 41: 722-730.
Kemper C, Verbsky JW, Price JD, Atkinson JP. T-cell stimulation and regulation: with complements from CD46. Immunol. Res. 2005; 32: 31-43.
Liu D, Zhang T, Marshall AJ, Okkenhaug K, Vanhaesebroeck B, Uzonna JE. The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J. Immunol. 2009; 183: 1921-1933.
Gao Q, Qiu SJ, Fan J et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 2007; 25: 2586-2593.
Li YW, Qiu SJ, Fan J et al. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J. Hepatol. 2011; 54: 497-505.
Ruitenberg JJ, Boyce C, Hingorani R, Putnam A, Ghanekar SA. Rapid assessment of in vitro expanded human regulatory T cell function. J. Immunol. Methods 2011; 372: 95-106.
Frentsch M, Arbach O, Kirchhoff D et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 2005; 11: 1118-1124.
Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006; 203: 1701-1711.
Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 2007; 13: 4345-4354.
Croci DO, Zacarias Fluck MF, Rico MJ et al. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol. Immunother. 2007; 56: 1687-1700.
Zhu XD, Zhang JB, Zhuang PY et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J. Clin. Oncol. 2008; 26: 2707-2716.
Curiel TJ, Coukos G, Zou L et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004; 10: 942-949.
Klein S, Kretz C, Krammer PH, Kuhn A. CD127low/- and FoxP3+expression levels characterize different regulatory T cell populations in human peripheral blood. J. Invest. Dermatol. 2010; 130: 492-499.
Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000; 25: 25-29.
Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421: 388-392.
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151-1164.
Kleinewietfeld M, Starke M, Di Mitri D et al. CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. Blood 2009; 113: 827-836.
Singh N, Yamamoto M, Takami M et al. CD4(+)CD25(+) regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis. J. Immunol. 2010; 184: 94-104.
Ono M, Yaguchi H, Ohkura N et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007; 446: 685-689.
Bach JF. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 2003; 3: 189-198.
Truscott SM, Abate G, Price JD, Kemper C, Atkinson JP, Hoft DF. CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses. Infect. Immun. 2010; 78: 5295-5306.
Loertscher R, Lavery P. The role of glycosyl phosphatidyl inositol (GPI)-anchored cell surface proteins in T-cell activation. Transpl. Immunol. 2002; 9: 93-96.
Gao Q, Wang XY, Qiu SJ et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin. Cancer Res. 2009; 15: 971-979.
Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat. Med. 2005; 11: 1113-1117.
Mizukami Y, Kono K, Kawaguchi Y et al. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br. J. Cancer 2008; 98: 148-153.
Shen X, Li N, Li H, Zhang T, Wang F, Li Q. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2010; 136: 1745-1754.
Yang XH, Yamagiwa S, Ichida T et al. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J. Hepatol. 2006; 45: 254-262.
Toledo F, Wahl GM. MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int. J. Biochem. Cell Biol. 2007; 39: 1476-1482.
Jenner J, Kerst G, Handgretinger R, Muller I. Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells. Exp. Hematol. 2006; 34: 1212-1218.
Deng L, Zhang H, Luan Y et al. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Clin. Cancer Res. 2010; 16: 4105-4112.
Gandhi R, Kumar D, Burns EJ et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat. Immunol. 2010; 11: 846-853.
Gobert M, Treilleux I, Bendriss-Vermare N et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009; 69: 2000-2009.
Shevach EM. Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med. 2001; 193: F41-46.
Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565-1570.
Marmor MD, Julius M. The function of GPI-anchored proteins in T cell development, activation and regulation of homeostasis. J. Biol. Regul. Homeost. Agents 2000; 14: 99-115.
2010; 78
2007; 39
2010; 11
2009; 69
2010; 16
2007; 446
2000; 25
2006; 34
2002; 9
2008; 18
2005; 41
2006; 18
2011; 54
2006; 6
2009; 113
2008; 98
2010; 184
1995; 155
2009; 131
2011; 372
2007; 56
2007; 13
2009; 27
2011; 331
2011; 232
2004; 10
2006; 45
2000; 14
2001; 193
2010; 136
2008; 26
2009; 100
2003; 3
2010; 130
2005; 32
2009; 183
2009; 3
2006; 203
2003; 421
2010; 5
2005; 11
2007; 25
2009; 15
2011; 241
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_36_1
e_1_2_6_14_1
e_1_2_6_35_1
e_1_2_6_11_1
e_1_2_6_34_1
e_1_2_6_12_1
e_1_2_6_33_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_38_1
e_1_2_6_16_1
e_1_2_6_37_1
e_1_2_6_42_1
e_1_2_6_43_1
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_41_1
e_1_2_6_40_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
Marmor MD (e_1_2_6_39_1) 2000; 14
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_29_1
e_1_2_6_44_1
e_1_2_6_28_1
e_1_2_6_45_1
e_1_2_6_27_1
e_1_2_6_46_1
e_1_2_6_26_1
e_1_2_6_47_1
References_xml – reference: Gao Q, Qiu SJ, Fan J et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 2007; 25: 2586-2593.
– reference: Croci DO, Zacarias Fluck MF, Rico MJ et al. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol. Immunother. 2007; 56: 1687-1700.
– reference: Loertscher R, Lavery P. The role of glycosyl phosphatidyl inositol (GPI)-anchored cell surface proteins in T-cell activation. Transpl. Immunol. 2002; 9: 93-96.
– reference: Klein S, Kretz C, Krammer PH, Kuhn A. CD127low/- and FoxP3+expression levels characterize different regulatory T cell populations in human peripheral blood. J. Invest. Dermatol. 2010; 130: 492-499.
– reference: Frentsch M, Arbach O, Kirchhoff D et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 2005; 11: 1118-1124.
– reference: Zhu XD, Zhang JB, Zhuang PY et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J. Clin. Oncol. 2008; 26: 2707-2716.
– reference: Quezada SA, Peggs KS, Simpson TR, Allison JP. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol. Rev. 2011; 241: 104-118.
– reference: Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006; 203: 1701-1711.
– reference: Yang XH, Yamagiwa S, Ichida T et al. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J. Hepatol. 2006; 45: 254-262.
– reference: Ju MJ, Qiu SJ, Fan J et al. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am. J. Clin. Pathol. 2009; 131: 498-510.
– reference: Gandhi R, Kumar D, Burns EJ et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat. Immunol. 2010; 11: 846-853.
– reference: Marmor MD, Julius M. The function of GPI-anchored proteins in T cell development, activation and regulation of homeostasis. J. Biol. Regul. Homeost. Agents 2000; 14: 99-115.
– reference: Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 2007; 13: 4345-4354.
– reference: Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421: 388-392.
– reference: Singh N, Yamamoto M, Takami M et al. CD4(+)CD25(+) regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis. J. Immunol. 2010; 184: 94-104.
– reference: Truscott SM, Abate G, Price JD, Kemper C, Atkinson JP, Hoft DF. CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses. Infect. Immun. 2010; 78: 5295-5306.
– reference: Hawiger D, Wan YY, Eynon EE, Flavell RA. The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell-mediated peripheral T cell unresponsiveness. Nat. Immunol. 2010; 11: 962-968.
– reference: Long ET, Baker S, Oliveira V, Sawitzki B, Wood KJ. Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice. PLoS ONE 2010; 5: e8894.
– reference: Kemper C, Verbsky JW, Price JD, Atkinson JP. T-cell stimulation and regulation: with complements from CD46. Immunol. Res. 2005; 32: 31-43.
– reference: Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006; 6: 295-307.
– reference: Ju MJ, Qiu SJ, Gao Q et al. Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Sci. 2009; 100: 1267-1274.
– reference: Shen X, Li N, Li H, Zhang T, Wang F, Li Q. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2010; 136: 1745-1754.
– reference: Bonnet A, Lagarrigue S, Liaubet L, Robert-Granie C, Sancristobal M, Tosser-Klopp G. Pathway results from the chicken data set using GOTM, Pathway Studio and Ingenuity softwares. BMC Proc. 2009; 3 (Suppl. 4): S11.
– reference: Gao Q, Wang XY, Qiu SJ et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin. Cancer Res. 2009; 15: 971-979.
– reference: Curiel TJ, Coukos G, Zou L et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004; 10: 942-949.
– reference: Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565-1570.
– reference: Jenner J, Kerst G, Handgretinger R, Muller I. Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells. Exp. Hematol. 2006; 34: 1212-1218.
– reference: Kleinewietfeld M, Starke M, Di Mitri D et al. CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. Blood 2009; 113: 827-836.
– reference: Shevach EM. Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med. 2001; 193: F41-46.
– reference: Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000; 25: 25-29.
– reference: Liu D, Zhang T, Marshall AJ, Okkenhaug K, Vanhaesebroeck B, Uzonna JE. The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J. Immunol. 2009; 183: 1921-1933.
– reference: Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151-1164.
– reference: Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Curr. Opin. Genet. Dev. 2008; 18: 11-18.
– reference: Li YW, Qiu SJ, Fan J et al. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J. Hepatol. 2011; 54: 497-505.
– reference: Toledo F, Wahl GM. MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int. J. Biochem. Cell Biol. 2007; 39: 1476-1482.
– reference: Mizukami Y, Kono K, Kawaguchi Y et al. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br. J. Cancer 2008; 98: 148-153.
– reference: Gobert M, Treilleux I, Bendriss-Vermare N et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009; 69: 2000-2009.
– reference: Unitt E, Rushbrook SM, Marshall A et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005; 41: 722-730.
– reference: Ruitenberg JJ, Boyce C, Hingorani R, Putnam A, Ghanekar SA. Rapid assessment of in vitro expanded human regulatory T cell function. J. Immunol. Methods 2011; 372: 95-106.
– reference: Staun-Ram E, Miller A. Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-beta and role played in cell migration. J. Neuroimmunol. 2011; 232: 200-206.
– reference: Sugimoto N, Oida T, Hirota K et al. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 2006; 18: 1197-1209.
– reference: Deng L, Zhang H, Luan Y et al. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Clin. Cancer Res. 2010; 16: 4105-4112.
– reference: Bach JF. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 2003; 3: 189-198.
– reference: Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat. Med. 2005; 11: 1113-1117.
– reference: Salama P, Phillips M, Grieu F et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 2009; 27: 186-192.
– reference: Ono M, Yaguchi H, Ohkura N et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007; 446: 685-689.
– volume: 372
  start-page: 95
  year: 2011
  end-page: 106
  article-title: Rapid assessment of in vitro expanded human regulatory T cell function
  publication-title: J. Immunol. Methods
– volume: 18
  start-page: 11
  year: 2008
  end-page: 18
  article-title: Immune surveillance: a balance between protumor and antitumor immunity
  publication-title: Curr. Opin. Genet. Dev.
– volume: 421
  start-page: 388
  year: 2003
  end-page: 392
  article-title: Activation of human CD4+ cells with CD3 and CD46 induces a T‐regulatory cell 1 phenotype
  publication-title: Nature
– volume: 25
  start-page: 25
  year: 2000
  end-page: 29
  article-title: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium
  publication-title: Nat. Genet.
– volume: 11
  start-page: 1113
  year: 2005
  end-page: 1117
  article-title: A live‐cell assay to detect antigen‐specific CD4+ T cells with diverse cytokine profiles
  publication-title: Nat. Med.
– volume: 331
  start-page: 1565
  year: 2011
  end-page: 1570
  article-title: Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
  publication-title: Science
– volume: 15
  start-page: 971
  year: 2009
  end-page: 979
  article-title: Overexpression of PD‐L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma
  publication-title: Clin. Cancer Res.
– volume: 9
  start-page: 93
  year: 2002
  end-page: 96
  article-title: The role of glycosyl phosphatidyl inositol (GPI)‐anchored cell surface proteins in T‐cell activation
  publication-title: Transpl. Immunol.
– volume: 3
  start-page: 189
  year: 2003
  end-page: 198
  article-title: Regulatory T cells under scrutiny
  publication-title: Nat. Rev. Immunol.
– volume: 184
  start-page: 94
  year: 2010
  end-page: 104
  article-title: CD4(+)CD25(+) regulatory T cells resist a novel form of CD28‐ and Fas‐dependent p53‐induced T cell apoptosis
  publication-title: J. Immunol.
– volume: 155
  start-page: 1151
  year: 1995
  end-page: 1164
  article-title: Immunologic self‐tolerance maintained by activated T cells expressing IL‐2 receptor alpha‐chains (CD25). Breakdown of a single mechanism of self‐tolerance causes various autoimmune diseases
  publication-title: J. Immunol.
– volume: 203
  start-page: 1701
  year: 2006
  end-page: 1711
  article-title: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 T reg cells
  publication-title: J. Exp. Med.
– volume: 45
  start-page: 254
  year: 2006
  end-page: 262
  article-title: Increase of CD4+ CD25+ regulatory T‐cells in the liver of patients with hepatocellular carcinoma
  publication-title: J. Hepatol.
– volume: 69
  start-page: 2000
  year: 2009
  end-page: 2009
  article-title: Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome
  publication-title: Cancer Res.
– volume: 193
  start-page: F41
  year: 2001
  end-page: 46
  article-title: Certified professionals: CD4(+)CD25(+) suppressor T cells
  publication-title: J. Exp. Med.
– volume: 25
  start-page: 2586
  year: 2007
  end-page: 2593
  article-title: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
  publication-title: J. Clin. Oncol.
– volume: 100
  start-page: 1267
  year: 2009
  end-page: 1274
  article-title: Combination of peritumoral mast cells and T‐regulatory cells predicts prognosis of hepatocellular carcinoma
  publication-title: Cancer Sci.
– volume: 98
  start-page: 148
  year: 2008
  end-page: 153
  article-title: Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer
  publication-title: Br. J. Cancer
– volume: 34
  start-page: 1212
  year: 2006
  end-page: 1218
  article-title: Increased alpha2,6‐sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells
  publication-title: Exp. Hematol.
– volume: 41
  start-page: 722
  year: 2005
  end-page: 730
  article-title: Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T‐regulatory cells
  publication-title: Hepatology
– volume: 14
  start-page: 99
  year: 2000
  end-page: 115
  article-title: The function of GPI‐anchored proteins in T cell development, activation and regulation of homeostasis
  publication-title: J. Biol. Regul. Homeost. Agents
– volume: 113
  start-page: 827
  year: 2009
  end-page: 836
  article-title: CD49d provides access to “untouched” human Foxp3+ Treg free of contaminating effector cells
  publication-title: Blood
– volume: 446
  start-page: 685
  year: 2007
  end-page: 689
  article-title: Foxp3 controls regulatory T‐cell function by interacting with AML1/Runx1
  publication-title: Nature
– volume: 11
  start-page: 1118
  year: 2005
  end-page: 1124
  article-title: Direct access to CD4+ T cells specific for defined antigens according to CD154 expression
  publication-title: Nat. Med.
– volume: 27
  start-page: 186
  year: 2009
  end-page: 192
  article-title: Tumor‐infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer
  publication-title: J. Clin. Oncol.
– volume: 241
  start-page: 104
  year: 2011
  end-page: 118
  article-title: Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
  publication-title: Immunol. Rev.
– volume: 26
  start-page: 2707
  year: 2008
  end-page: 2716
  article-title: High expression of macrophage colony‐stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma
  publication-title: J. Clin. Oncol.
– volume: 5
  start-page: e8894
  year: 2010
  article-title: Alpha‐1,2‐mannosidase and hence N‐glycosylation are required for regulatory T cell migration and allograft tolerance in mice
  publication-title: PLoS ONE
– volume: 32
  start-page: 31
  year: 2005
  end-page: 43
  article-title: T‐cell stimulation and regulation: with complements from CD46
  publication-title: Immunol. Res.
– volume: 6
  start-page: 295
  year: 2006
  end-page: 307
  article-title: Regulatory T cells, tumour immunity and immunotherapy
  publication-title: Nat. Rev. Immunol.
– volume: 11
  start-page: 962
  year: 2010
  end-page: 968
  article-title: The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell‐mediated peripheral T cell unresponsiveness
  publication-title: Nat. Immunol.
– volume: 11
  start-page: 846
  year: 2010
  end-page: 853
  article-title: Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell‐like and Foxp3(+) regulatory T cells
  publication-title: Nat. Immunol.
– volume: 183
  start-page: 1921
  year: 2009
  end-page: 1933
  article-title: The p110delta isoform of phosphatidylinositol 3‐kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells
  publication-title: J. Immunol.
– volume: 13
  start-page: 4345
  year: 2007
  end-page: 4354
  article-title: A unique subset of CD4 CD25 Foxp3 T cells secreting interleukin‐10 and transforming growth factor‐beta1 mediates suppression in the tumor microenvironment
  publication-title: Clin. Cancer Res.
– volume: 136
  start-page: 1745
  year: 2010
  end-page: 1754
  article-title: Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma
  publication-title: J. Cancer Res. Clin. Oncol.
– volume: 232
  start-page: 200
  year: 2011
  end-page: 206
  article-title: Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon‐beta and role played in cell migration
  publication-title: J. Neuroimmunol.
– volume: 56
  start-page: 1687
  year: 2007
  end-page: 1700
  article-title: Dynamic cross‐talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment
  publication-title: Cancer Immunol. Immunother.
– volume: 131
  start-page: 498
  year: 2009
  end-page: 510
  article-title: Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection
  publication-title: Am. J. Clin. Pathol.
– volume: 3
  start-page: S11
  year: 2009
  article-title: Pathway results from the chicken data set using GOTM, Pathway Studio and Ingenuity softwares
  publication-title: BMC Proc.
– volume: 16
  start-page: 4105
  year: 2010
  end-page: 4112
  article-title: Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients
  publication-title: Clin. Cancer Res.
– volume: 39
  start-page: 1476
  year: 2007
  end-page: 1482
  article-title: MDM2 and MDM4: p53 regulators as targets in anticancer therapy
  publication-title: Int. J. Biochem. Cell Biol.
– volume: 18
  start-page: 1197
  year: 2006
  end-page: 1209
  article-title: Foxp3‐dependent and ‐independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis
  publication-title: Int. Immunol.
– volume: 10
  start-page: 942
  year: 2004
  end-page: 949
  article-title: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
  publication-title: Nat. Med.
– volume: 130
  start-page: 492
  year: 2010
  end-page: 499
  article-title: CD127low/‐ and FoxP3+expression levels characterize different regulatory T cell populations in human peripheral blood
  publication-title: J. Invest. Dermatol.
– volume: 54
  start-page: 497
  year: 2011
  end-page: 505
  article-title: Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection
  publication-title: J. Hepatol.
– volume: 78
  start-page: 5295
  year: 2010
  end-page: 5306
  article-title: CD46 engagement on human CD4+ T cells produces T regulatory type 1‐like regulation of antimycobacterial T cell responses
  publication-title: Infect. Immun.
– ident: e_1_2_6_15_1
  doi: 10.1038/sj.bjc.6604149
– ident: e_1_2_6_45_1
  doi: 10.1093/intimm/dxl060
– ident: e_1_2_6_23_1
  doi: 10.1038/75556
– ident: e_1_2_6_17_1
  doi: 10.1158/1078-0432.CCR-10-1073
– ident: e_1_2_6_38_1
  doi: 10.1016/j.jneuroim.2010.10.015
– ident: e_1_2_6_30_1
  doi: 10.1007/s00432-010-0833-8
– ident: e_1_2_6_27_1
  doi: 10.1038/nm1292
– ident: e_1_2_6_18_1
  doi: 10.1200/JCO.2008.18.7229
– ident: e_1_2_6_29_1
  doi: 10.1016/j.jhep.2006.01.036
– ident: e_1_2_6_24_1
  doi: 10.1186/1753-6561-3-s4-s11
– ident: e_1_2_6_31_1
  doi: 10.1385/IR:32:1-3:031
– ident: e_1_2_6_35_1
  doi: 10.4049/jimmunol.0900753
– ident: e_1_2_6_33_1
  doi: 10.1128/IAI.00513-10
– volume: 14
  start-page: 99
  year: 2000
  ident: e_1_2_6_39_1
  article-title: The function of GPI‐anchored proteins in T cell development, activation and regulation of homeostasis
  publication-title: J. Biol. Regul. Homeost. Agents
– ident: e_1_2_6_9_1
  doi: 10.1016/j.jhep.2010.07.044
– ident: e_1_2_6_21_1
  doi: 10.1002/hep.20644
– ident: e_1_2_6_34_1
  doi: 10.1016/j.biocel.2007.03.022
– ident: e_1_2_6_25_1
  doi: 10.1038/nri1026
– ident: e_1_2_6_44_1
  doi: 10.1038/ni.1929
– ident: e_1_2_6_36_1
  doi: 10.1016/j.exphem.2006.04.016
– ident: e_1_2_6_16_1
  doi: 10.1158/0008-5472.CAN-08-2360
– ident: e_1_2_6_28_1
  doi: 10.1038/nm1293
– ident: e_1_2_6_14_1
  doi: 10.1038/nm1093
– ident: e_1_2_6_26_1
  doi: 10.1084/jem.193.11.F41
– ident: e_1_2_6_46_1
  doi: 10.1038/jid.2009.313
– ident: e_1_2_6_3_1
  doi: 10.1126/science.1203486
– ident: e_1_2_6_43_1
  doi: 10.1038/ni.1915
– ident: e_1_2_6_47_1
  doi: 10.1182/blood-2008-04-150524
– ident: e_1_2_6_13_1
  doi: 10.1158/1078-0432.CCR-07-0472
– ident: e_1_2_6_7_1
  doi: 10.1200/JCO.2007.15.6521
– ident: e_1_2_6_11_1
  doi: 10.4049/jimmunol.155.3.1151
– ident: e_1_2_6_42_1
  doi: 10.1038/nature05673
– ident: e_1_2_6_8_1
  doi: 10.1309/AJCP86PPBNGOHNNL
– ident: e_1_2_6_10_1
  doi: 10.1111/j.1349-7006.2009.01182.x
– ident: e_1_2_6_20_1
  doi: 10.1084/jem.20060772
– ident: e_1_2_6_6_1
  doi: 10.1200/JCO.2006.09.4565
– ident: e_1_2_6_19_1
  doi: 10.1158/1078-0432.CCR-08-1608
– ident: e_1_2_6_2_1
  doi: 10.1016/j.gde.2007.12.007
– ident: e_1_2_6_37_1
  doi: 10.1371/journal.pone.0008894
– ident: e_1_2_6_32_1
  doi: 10.1038/nature01315
– ident: e_1_2_6_41_1
  doi: 10.4049/jimmunol.0901099
– ident: e_1_2_6_12_1
  doi: 10.1038/nri1806
– ident: e_1_2_6_22_1
  doi: 10.1016/j.jim.2011.07.001
– ident: e_1_2_6_4_1
  doi: 10.1007/s00262-007-0343-y
– ident: e_1_2_6_5_1
  doi: 10.1111/j.1600-065X.2011.01007.x
– ident: e_1_2_6_40_1
  doi: 10.1016/S0966-3274(02)00013-8
SSID ssj0004075
Score 2.1904693
Snippet Background and Aim Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different...
Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1555
SubjectTerms Adult
Antigens, Surface - analysis
B-Lymphocyte Subsets - immunology
Carcinoma, Hepatocellular - genetics
Carcinoma, Hepatocellular - immunology
Carcinoma, Hepatocellular - pathology
Case-Control Studies
Female
Gene Expression Profiling - methods
Gene Expression Regulation, Neoplastic
gene microarray
hepatocellular carcinoma
Humans
Immune Tolerance - immunology
Immunophenotyping
immunosuppression
Liver Neoplasms - genetics
Liver Neoplasms - immunology
Liver Neoplasms - pathology
Lymphocytes, Tumor-Infiltrating - immunology
Male
Middle Aged
Oligonucleotide Array Sequence Analysis - methods
regulatory T cell
T-Lymphocytes, Regulatory - immunology
Tumor Escape - immunology
tumor immuno-escape
Title Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients
URI https://api.istex.fr/ark:/67375/WNG-62F2G1R4-Q/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.12202
https://www.ncbi.nlm.nih.gov/pubmed/23517245
https://www.proquest.com/docview/1433266250
https://www.proquest.com/docview/1439228267
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEF5KBfHFeu-pF1YR8SWHZDebZPFJxHOOBQuWFvsghL2lR2qTQy5i_fXObC5aqSK-hTBJ9jKzM7P59htCnmfcaC1dEXAdZUFsiijQEq5SCe6mcODxjUf5HiSr43j_RJxskVfjWZieH2LacEPL8Os1GrjSza9GfrqeR4x5IknEamFAdPiTOiruSXbB44lAgp4NrEIexTM-eckXXcNh_XZVoHk5bvWOZ7FDPo1N7vEmZ_Ou1XPz_Tc2x__s0y1ycwhI6eteg26TLVfeIdffD7_c75KLd7j923bneJSf1n3p-qq-oEcUN_0biju5dO3hInRTI3s4LhZUlZYiiJc23aYH236Fm6YvVkE_l3QNjrCt8B2IhKUGixqV1bmiA9Vrc48cL94evVkFQ72GwHCZsIDbJFTKZhKyJFEI6cK0iFlRJJkoIgeRhE6szZRykQq11akRVicZMiKmzIKa8Ptku6xKt0soJFmWOSYTGaexkwbyWM2l4JZxaZQKZ-TlOHO5GcjMsabGl3xKak7XuR_KGXk2iW56Bo-rhF746Z8kVH2GkLdU5B8PlnnCFmwZHcb5hxl5OupHDoaIg6RKV3UN5FAcQmHoefhXGckgyU3SGXnQK9f0RcYFBJOxgK55FflzY_P95cpf7P276ENyg_lCHoiOe0S227pzjyGcavUTbzc_ACPAG64
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKKwEX3tDlaRCgXrJKnKcPHBBlH32sRLUVvQXbcXar0mSVB7D8Jv4K_4kZJxsoKohLD9ysaOT4MeOZcb58Q8jzyFVScp1arnQiy1OpY0kOrZCDu0k1eHxlUL6TYHTo7Rz5R2vk2-pfmIYfortwQ8sw5zUaOF5I_2rls3nfYZC8t5DKXb38DAlb-Wq8Dbv7grHB2-mbkdXWFLCUywNmuUlgC5FEHCJ5P_W5tsPUY2kaRH7qaPB2MkiSSAjtCFsmMlR-IoMIWftClsBUXOj3EtnACuLI1L998JOsymtofcHH-hYHzW55jAxuaDXUM95vAzfyy3mh7dlI2bi6wXXyfbVIDcLlpF9Xsq--_sYf-b-s4g1yrY256evGSG6SNZ3dIpf3W1TBbbIc4w13VZ8iWwEt9AxLmuXFkk4pftcoKV5W07lBxNBFgQTpeB5SkSUUccq0rBcNnvgTPFRNPQ56nNE5-Poqxz4Q7EsV1m3K8lNBWzbb8g45vJCJ3yXrWZ7pTUIhj0yYZjzgXuhpriBVly733YS5XAlh98jWSlVi1fK1Y9mQj3GXt83msdm6HnnWiS4akpLzhF4afeskRHGCqL7Qj99PhnHABmzoHHjxux55ulLIGM4aXCSR6bwuIU10IdqHmdt_leEM8vgg7JF7jTZ3b2SuD_Gy58PUjE7-ebDxznBkGvf_XfQJuTKa7u_Fe-PJ7gNylZm6JQgGfEjWq6LWjyB6rORjY7SUfLho_f4B1Wl6yw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JbtRAEG2FRIq4sC_D2iBAXDyyu731gQNimCWBEUSJyM305hkUYo-8AMMv8St8FNXtBYIC4pIDt5ZVavdS1VXVfn6F0KOYSiGYTh0qvNjxZeo5gkErYuBuUg0eX1qU7zycHvg7h8HhBvrW_QvT8EP0F27GMux5bQx8pdJfjXyxHHoEcvcWUbmr158hXyufzUawuY8JGb_cfzF12pICjqQsJA5Vocu5ihkE8kEaMO1GqU_SNIyD1NPg7ESoVMy59rgrlIhkoEQYG9K-iCiYCYV-z6EtP3SZqRMx2vvJVeU3rL7gYgOHgWK3NEYWNtQN9YTz2zL7-OW0yPZkoGw93fgi-t6tUQNwORrWlRjKr7_RR_4ni3gJXWgjbvy8MZHLaENnV9D26xZTcBWtZ-Z-u6qPDVcBLvTCFDTLizXex-arRonNVTVeWjwMXhWGHt2chphnChuUMi7rVYMm_gQPZVONA3_I8BI8fZWbPgzUF0tTtSnLjzluuWzLa-jgTCZ-HW1meaZvIgxZpCKasJD5ka-ZhERdUBZQRSiTnLsD9LTTlES2bO2maMjHpM_aFsvEbt0APexFVw1FyWlCT6y69RK8ODKYvihI3s0nSUjGZOLt-cnbAXrQ6WMCJ41ZJJ7pvC4hSaQQ68PM3b_KMAJZfBgN0I1Gmfs3EhpAtOwHMDWrkn8ebLIzmdrGrX8XvY-234zGyavZfPc2Ok9s0RKDBLyDNqui1nchdKzEPWuyGL0_a_X-Ad4reXo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intratumoral+regulatory+T+cells+with+higher+prevalence+and+more+suppressive+activity+in+hepatocellular+carcinoma+patients&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Wu%2C+Han&rft.au=Chen%2C+Pei&rft.au=Liao%2C+Rui&rft.au=Li%2C+Yi%E2%80%90Wei&rft.date=2013-09-01&rft.issn=0815-9319&rft.eissn=1440-1746&rft.volume=28&rft.issue=9&rft.spage=1555&rft.epage=1564&rft_id=info:doi/10.1111%2Fjgh.12202&rft.externalDBID=10.1111%252Fjgh.12202&rft.externalDocID=JGH12202
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon